Rodolphe Lebrun
Directeur Financier/CFO chez THERAVET SA
Provenance du réseau au premier degré de Rodolphe Lebrun
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rodolphe Lebrun via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anifera Ltd. | Director/Board Member | ||
HEC-ULG Management School | College/University | Graduate Degree | |
University of Liege | College/University | Doctorate Degree | |
Funny Mountain SA | Director/Board Member | ||
Neuromedia SA | Director/Board Member | ||
Caselia SA
Caselia SA HomebuildingConsumer Durables Caselia SA is a Belgian company that specializes in real estate property development and building construction services. The private company is based in Oudergem, Belgium and has subsidiaries in France. Caselia was founded in 2007 and Louis Amory has been the CEO of the company since 2020. | Homebuilding | Director/Board Member | |
Investsud SA
Investsud SA Investment ManagersFinance INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium. | Investment Managers | Private Equity Investor | |
Flanders Vaccine | Director/Board Member | ||
AnimAb BV
AnimAb BV BiotechnologyHealth Technology AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020. | Biotechnology | General Counsel | |
Ghent University | College/University | Doctorate Degree | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
ViroVet NV
ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Vetsina Animal Diagnostics Ltd. | Chief Executive Officer | ||
Roslin Technologies Ltd.
Roslin Technologies Ltd. BiotechnologyHealth Technology Roslin Technologies Ltd. engages in the provision of agriculture biotechnology solutions. It offers genome sequencing, genotyping, gene editing, transgenics, phenotyping, and bioinformatics. The company is headquartered in Midlothian, the United Kingdom. | Biotechnology | Chief Operating Officer | |
ProSkelia BV | Founder | ||
The Open University Business School | College/University | Masters Business Admin | |
The Royal Veterinary College | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Chief Executive Officer | |
Advanced Animal Diagnostics, Inc.
Advanced Animal Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Pensionnat Henri Jaspar | Director/Board Member | ||
Glob-Co SRL | Director/Board Member | ||
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Corporate Officer/Principal | |
Apaxen SA
Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Founder | |
Pepric NV
Pepric NV Miscellaneous Commercial ServicesCommercial Services Pepric NV develops imaging technology. It offers sensitive imaging systems with a long observation window for in-vivo molecular and functional imaging addressing pharmaceutical applications in drug development, pre-clinical testing, diagnostic imaging and translational medicine in general. The company was founded Stephanie Laura Gerard Claire Teughels in 2009 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Hôpital Erasme
Hôpital Erasme Hospital/Nursing ManagementHealth Services Part of Université Libre de Bruxelles, Hôpital Erasme is a medical facility located in Brussels, Belgium. The hospital offers polyclinics in Nivelles and Brussels, as well as specialized centers in psychiatry, geriatrics, and traumatology. | Hospital/Nursing Management | Corporate Officer/Principal | |
Université Catholique de Louvain | College/University | Doctorate Degree |
Statistiques
Internationale
Belgique | 20 |
Royaume-Uni | 7 |
Etats-Unis | 4 |
Pays-Bas | 2 |
Suisse | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 9 |
Commercial Services | 4 |
Finance | 3 |
Consumer Durables | 2 |
Opérationnelle
Director/Board Member | 14 |
Corporate Officer/Principal | 7 |
Founder | 5 |
Doctorate Degree | 5 |
Chief Executive Officer | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Rodolphe Lebrun
- Connexions Sociétés